# Foghorn Therapeutics Inc. (FHTX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Foghorn Therapeutics Inc. (FHTX) is 5/100, ranked against 24,000+ stocks in 35 markets (Quality 17, Value 28, Momentum 28, each scored against its sector).

- StockRank: 5/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 17, Value 28, Momentum 28: each a 0-100 percentile within Healthcare.
- Position: #25,041 overall, #2,468 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 2.05 USD on 26 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/FHTX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker